Skip to main content

Correction to: Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model

The Original Article was published on 17 August 2020

Correction to: EJNMMI Res 10, 96 (2020)

https://doi.org/10.1186/s13550-020-00679-1

Following publication of the original article [1], the authors reported that the captions of Figs. 7 and 8 had been erroneously swapped in the article.

Fig. 7
figure 1

Gross pathology and microdosimetry for P5. a Pre-treatment T2 FLAIR 1 month prior to therapy. b Formalin-fixed gross pathologic example of involved hemisphere with significant central tumor necrosis. c Microdosimetry showing the absorbed-dose distribution in dog P5 if the dog had survived. At the time of death, only 15% of the absorbed-doses shown had been delivered based on the half-life of 90Y. d Post-explant microCT showing gross distribution of glass microspheres. Image is a maximum intensity projection of 100 microCT slices with a combined thickness of 900 um. A preference for deposition in the peri-necrotic region of tumor can be seen (white arrows). Occasional filling of end-arterioles/capillaries with microspheres can be visualized (red arrow)

Fig. 8
figure 2

P4 T2 FLAIR at a 1 month pre-treatment, b 1 month post-treatment and c 6 months post-treatment

The figures have now been corrected in the published original article.

In addition, please find the (corrected) figures in this correction for reference.

Reference

  1. Pasciak AS, Manupipatpong S, Hui FK, et al. Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model. EJNMMI Res. 2020;10:96. https://doi.org/10.1186/s13550-020-00679-1..

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander S. Pasciak.

Additional information

The original article can be found online at https://doi.org/10.1186/s13550-020-00679-1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pasciak, A.S., Manupipatpong, S., Hui, F.K. et al. Correction to: Yttrium-90 radioembolization as a possible new treatment for brain cancer: proof of concept and safety analysis in a canine model. EJNMMI Res 10, 104 (2020). https://doi.org/10.1186/s13550-020-00691-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13550-020-00691-5